SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-000691
Filing Date
2019-01-14
Accepted
2019-01-14 17:20:35
Documents
44
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1118_oramedpharma.htm 10-Q 375915
2 CONSULTING AGREEMENT, DATED DECEMBER 12, 2018, BETWEEN ORAMED LTD. AND JOSHUA HE f10q1118ex10-1_oramedpharma.htm EX-10.1 161966
3 CERTIFICATION f10q1118ex31-1_oramedpharma.htm EX-31.1 13346
4 CERTIFICATION f10q1118ex31-2_oramedpharma.htm EX-31.2 14316
5 CERTIFICATION f10q1118ex32-1_oramedpharma.htm EX-32.1 5231
6 CERTIFICATION f10q1118ex32-2_oramedpharma.htm EX-32.2 6079
7 GRAPHIC img_001.jpg GRAPHIC 1660
8 GRAPHIC img_002.jpg GRAPHIC 1288
9 GRAPHIC img_003.jpg GRAPHIC 1016
10 GRAPHIC ex10-1_001.jpg GRAPHIC 11881
  Complete submission text file 0001213900-19-000691.txt   2714439

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE ormp-20181130.xml EX-101.INS 432065
12 XBRL SCHEMA FILE ormp-20181130.xsd EX-101.SCH 29366
13 XBRL CALCULATION FILE ormp-20181130_cal.xml EX-101.CAL 34454
14 XBRL DEFINITION FILE ormp-20181130_def.xml EX-101.DEF 105659
15 XBRL LABEL FILE ormp-20181130_lab.xml EX-101.LAB 287720
16 XBRL PRESENTATION FILE ormp-20181130_pre.xml EX-101.PRE 180604
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 19525672
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences